Ovintiv Inc. (OVV): what the price assumes

In the published model solve dated 2026-Q2, anchored at $57.89, Ovintiv Inc. (OVV) is priced for +10.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/OVV

Headline

FieldValue
TickerOVV
CompanyOvintiv Inc.
Current price$57.89/sh
CompositionOil 40% / NGLs 24% / Natural gas 19% / Sales of purchased product 17% / Gathering and processing, and other 0%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)6.5%
Operating margin today9.7%
Margin compression (value-band)-3.2pp
Implied growth10.8%
Multiple paid12x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 11.2% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~5.5pp.

Reconcile: at the x-ray's 9.3% required return this reads ~0.2%/yr; the models below use their own rates.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.46σ
cohort percentile (of 46 peers)41
sustained it ~5 years at this level59%
implied end-window share0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset5.51x5expensive
Earnings1.41x4expensive
Relative3.61x2expensive
Growth0.82x3justifies

Families that justify the price: Growth Families that call it expensive: Asset, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.5%); the inversion above states its own rate.

Per-Model Detail (n=14)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$192.590.30xyesFCF base $2.3B, growth 7% (input: historical growth), terminal g 4.0%, WACC 7.5%, 5yr projection
DCF Exit MultipleGrowth$70.580.82xyesExit EV/EBITDA: 4.0x / 6.5x / 11.5x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelativenoP/E 22x (blended: static sector reference 10x + trailing (TTM) 60x), scenarios: 16.5x / 22.0x / 26.4x (bear / base = reference held flat / bull), EV/EBITDA 6x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$10.515.51xyesBV/sh $41.74, ROE (TTM) 2.3%, ke 9.3%
Two-Stage Excess ReturnAsset$6.019.63xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$37.631.54xyesRev $9.8B, growth 7% (input: historical growth; tapered), Terminal P/S: 1.2x / 1.6x / 2.0x (bear / base = today's held flat / bull, cap 6x)
Peter Lynch Fair ValueRelative$10.595.47xyesEPS $0.88, growth 2% (input: historical EPS growth), PEG=29.77 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$80.930.72xyesNormalized EBIT (5y avg op income, one-time charges added back) $2.81B × (1−15%) / WACC 7.5% → EPV (no growth)
Residual IncomeAsset$4.4013.16xyesBV $41.74 + 5yr PV of (ROE (TTM) 2.3% − Kₑ 9.3%) × BV; BV grows 1.5%/yr
Graham NumberAsset$28.792.01xyes√(22.5 × EPS $0.88 × BVPS $41.74) — Graham's conservative floor
EV/EBITDA RelativeRelativenoEBITDA $3.11B × sector EV/EBITDA 6.0x
FCF YieldEarnings$73.610.79xyesFCF $2266.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$28.482.03xyesEPS $0.88 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$29.871.94xyesBV $41.74 × (ROIC 5.4% / WACC 7.5%)
P/Sales SectorRelativenoRevenue $9.80B × sector P/S 1.2x
PEG Fair ValueRelative$33.091.75xyesEPS $0.88 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$9.546.07xyesEPS $0.88 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
USA Operationsoperatingenterprise$5.9bwithheldunresolved no unit value
Canadian Operationsoperatingenterprise$2.9bwithheldunresolved no unit value
Market Optimizationoperatingenterprise$79.0mwithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$3.1b
Net debt / NOPAT (after-tax)3.87x
Net debt / operating income (pre-tax)3.27x
Interest coverage2.4x
Share count CAGR (dilution)2.0%
Burning cashno

Bullet Takeaways

Bull Case

The single number that flips the verdict on Ovintiv is free cash flow, because for an oil and gas producer the reported earnings can lie while the cash does not. Q1 2026 makes the point starkly: the company posted a $630 million net loss, driven by impairments, yet generated $634 million of free cash flow in the same quarter (Ovintiv Q1 2026, stocktitan). The static valuation methods that anchor to book value and trailing GAAP earnings, which show a depressed return on equity near 1%, badly misread the business; the FCF-yield method, which capitalizes that $1.7 billion run-rate of cash, lands at $37 and the DCF methods reach the price. When you value Ovintiv on the cash it actually throws off, the picture is of a healthy producer, not a loss-maker.

The portfolio transformation is the structural change the price has not fully absorbed. Ovintiv sold its Anadarko assets for $3.0 billion and used the proceeds plus a $700 million note redemption to cut net debt below $3.3 billion by the end of April 2026, taking net debt to adjusted EBITDA below 0.8x (Ovintiv Q1 2026, stocktitan). The company is now focused on two of the best basins in North America: the oil-rich Permian (Q1 production 221 MBOE/d, 79% liquids) and the Montney (365 MBOE/d). Its filings note that quarterly revenue moves with benchmark prices, with Houston and WTI down 15% and 14% in the period (FY2025 10-K, accession 0001193125-26-064309), so a cleaner, lower-cost two-basin footprint at sub-0.8x leverage is built to generate cash across the price band.

The capital-return framework closes the loop and is the clearest catalyst. The board authorized a new $3.0 billion share repurchase program effective immediately and committed to returning at least 75% of full-year free cash flow through dividends and buybacks, alongside a $0.30 quarterly dividend (Ovintiv enhanced 2026 return framework, Globe and Mail). Against a peer cohort of Devon, EQT, Expand Energy, and Liberty, Ovintiv now carries one of the cleaner balance sheets, and Devon's own filing underscores the shared playbook: cash flow growth is the key tenet, pursued throughout commodity cycles (DVN FY2025 10-K, accession 0001193125-26-056485). Priced at about 14x mid-cycle operating income with a fortress balance sheet and 75% of free cash flow coming back, the bull case is a deleveraged producer returning cash at a reasonable multiple.

Bear Case

The price-to-fundamentals disconnect cuts the other way too, and the bear case starts there: the entire bull thesis depends on commodity prices the company does not control. The $630 million net loss and the impairments behind it were a direct consequence of lower benchmark prices, with Houston and WTI down 15% and 14% in the quarter. The mid-cycle earnings the valuation leans on are a normalized figure that assumes prices average through the cycle at levels that may not hold. If oil and gas settle into a lower band, the $634 million quarterly free cash flow that anchors the bull case compresses, the buyback shrinks, and the stock reprices on the lower cash generation. A producer is a leveraged bet on a price deck, and the price deck is the one variable nobody can forecast.

The asset-based methods are blunt about how little tangible support there is under the price. Simple Excess Return lands at $4.79, Two-Stage Excess Return at $2.54, and Residual Income at $1.81, all a fraction of the $52.39 price (June 27, 2026), because the trailing return on equity is near 1% and the business is currently earning well below its cost of capital on a GAAP basis. The reason only the growth-DCF reaches the price is that the price is a bet on mid-cycle economics that the current results do not show. That is a moat-and-durability premium for a commodity producer, which is exactly the kind of premium that evaporates fastest when sentiment on energy turns.

The operational and structural risks compound the commodity exposure. Ovintiv's plan requires $2.25 billion to $2.35 billion of annual capital just to hold production at 620 to 645 MBOE/d, so this is a treadmill business: a large share of cash flow must be reinvested simply to offset the steep decline rates of shale wells. The portfolio reshuffling, selling Anadarko, the prior NuVista-related activity, shows a company still actively reshaping itself, which carries integration and execution risk. There is also a measurement caveat worth flagging: the trailing operating-income figures from different sources diverge sharply here, so the exact multiple is sensitive to which basis you read. The bear case is the standard one for E&P: the cash looks great at today's strip, but the strip is the whole bet, and the asset value underneath offers almost no floor if prices fall.

Valuation

Ovintiv has to be valued on through-cycle economics, because its trailing GAAP results are distorted by impairments and a cyclical trough. The model recognizes this and prices the inversion on mid-cycle operating income: at $52.39 the market pays about 14x normalized operating income, implying roughly 8% annual operating growth for five years, computed at a 9.8% cost of capital with 4% terminal growth, where each point of cost of capital moves the implied growth about 5.8 points. On normalized earnings the priced-in assumption reads as within range.

The model dispersion is wide and needs interpreting. The growth and earnings-power methods that use normalized or cash figures cluster near or above the price (DCF Perpetual Growth $61, Earnings Power Value $73 on five-year average operating income, DCF Exit Multiple $50, FCF Yield $37), while the asset-based methods sit far below it (Simple Excess Return $4.79, Residual Income $1.81) because they read the trough-quarter return on equity. The honest read is that on mid-cycle cash generation Ovintiv is fairly-to-attractively priced, while on trailing trough earnings it looks expensive. The valuation is, at bottom, a bet on the commodity cycle: the methods that assume normalized prices support the stock, and the ones that read the trough do not. A measurement note: trailing operating income figures diverge materially across sources here, so treat the precise multiple as approximate.

Catalysts

Ovintiv reported Q1 2026 results on May 11, 2026, with $634 million of free cash flow and $1.2 billion of cash flow despite a $630 million net loss driven by impairments (Ovintiv Q1 2026, stocktitan). Montney production averaged 365 MBOE/d and Permian 221 MBOE/d (79% liquids), and full-year guidance was maintained at 205,000 to 212,000 barrels per day of oil and condensate on a $2.25 billion to $2.35 billion capital plan (Ovintiv Q1 2026 release, PR Newswire).

The forward setup is dominated by the balance-sheet transformation and the new return framework. The $3.0 billion Anadarko asset sale plus a $700 million note redemption cut net debt below $3.3 billion (under 0.8x EBITDA) by the end of April, and the board authorized a new $3.0 billion buyback while committing to return at least 75% of full-year free cash flow through dividends and buybacks, with a $0.30 quarterly dividend (Ovintiv enhanced 2026 return framework, Globe and Mail). The catalysts to watch are the oil and natural-gas price strip (the dominant driver), the pace of buyback execution against the $3.0 billion authorization, well productivity and capital efficiency in the Permian and Montney, and any further portfolio moves. The next quarterly print will show how much free cash flow the slimmed-down two-basin portfolio generates at the prevailing price deck.

Peer Cohorts (Per Segment, With Filing Citations)

USA Operations / Canadian Operations / Market Optimization (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive OVV report on boothcheck